OPINION Valve for life in the management of severe aortic...

OPINION
Valve for life in the management of severe aortic stenosis patients, are on a number of respectable cardiologist’s lips at conferences around the world, with a greater new emphasis, changing from survival and avoiding mortality to a longer term durability of the device for younger patients.

I am honestly amazed at how much information is being discussed and available for new medical educational accreditation for exactly the need and desire for product/s that our company is offering. Sooner or later the market in general will wake up and jump on board.

I’m not surprised in the least to see a depressed market cap designed that way combined with Tax sell off. Our technology is unique and disruptive and will only improve with greater funds for research, in the way of a takeover. Sure we are doing the daily chores of running the business at a pace of what I believe would be years to achieve something great on our own, however, it is IMHO success will be accelerated by a takeover.

The competitors know what we have and whether they are planning now or later, the catalysts outlined will see the company just ooze success. Great times ahead. Good luck